Current Practice in ADHD: Meet the Experts
- Continuing Education

Gain practical, evidence-based strategies for diagnosing and treating ADHD across the lifespan in this dynamic course. Learn the latest advances in pharmacologic and non-pharmacologic treatments, comorbidity management, and evolving diagnostic guidelines to enhance patient care.
- Live Online
This course is taught online in real time.
$290
This is the standard price, for a full list of profession pricing see below.
View All
Early Registration Deadline:
On This Page
Overview
Attention-Deficit/Hyperactivity Disorder (ADHD) is a prevalent and impairing neurodevelopmental disorder that affects individuals across the lifespan. While historically viewed as a childhood disorder, growing evidence supports its persistence into adolescence and adulthood. Despite extensive research, clinicians often face challenges in accurate diagnosis, differentiation from comorbid conditions, and implementation of evidence-based treatments. Additionally, recent advancements in pharmacologic and non-pharmacologic therapies, as well as updates to diagnostic criteria and practice guidelines, necessitate that clinicians keep abreast of best practices to ensure successful outcomes in patient care.
This new course aims to address common clinical challenges via updates from international experts. Faculty will discuss diagnostic complexities, the latest pharmacologic and non-pharmacologic treatment options, effective management of comorbid conditions, and population differences in symptom presentation. Participants will leave with up-to-date knowledge and tools to immediately implement with their patients. We welcome all mental health and primary care providers to join us!
Learning Objectives
- Apply updated diagnostic criteria and tools for identifying ADHD across different age and population groups.
- Evaluate current pharmacologic treatments, including emerging therapies, for ADHD management.
- Integrate non-pharmacologic approaches and behavioral interventions into individualized treatment plans.
- Discuss the interplay of ADHD and autism and develop strategies to address features of both conditions in clinical care.
- Summarize the prevalence of ADHD co-occurring with mood disorders, and current guidelines for starting and managing treatment.
- Describe the assessment and management of sleep disorders in patients with ADHD.
- Explain how ADHD manifests differently in women and girls.
Developed and Offered By:
Schedule
Friday, September 12, 2025
Welcome and Introduction
8:20-8:30 am
Screening, Diagnosis, and Measurement Based Care
Margaret Weiss
8:30-9:30 am
Optimizing Stimulant and Non Stimulant Therapy
Oscar Bukstein
9:30-10:30 am
Break
10:30-10:45 am
Psychological Treatments for ADHD
Mary Solanto
10:45-11:45 am
ADHD and Mood Disorders
Gregory Mattingly
11:45 am-12:45 pm
Lunch
12:45-1:30 pm
ADHD and Sleep Disruption
Mark Stein
1:30-2:30 pm
Complexities of ADHD in the Context of Autism
Robyn Thom
2:30-3:30 pm
Break
3:30-3:40 pm
Women and ADHD
Kathleen Nadeau
3:40-4:40 pm
Close Program
4:40-4:45 pm
Faculty
Margaret Weiss, MD, PhD, FRCP(C)
Course Director
- Director, Neurodevelopmental Clinic and Director of Clinical Research in Child Psychiatry, Cambridge Health Alliance/Cambridge Hospital
- Associate Professor of Psychiatry, Harvard Medical School
Karen Kuc, MPH
Course Director
- Director, Continuing Education in Psychiatry, Cambridge Health Alliance
- Associate in Psychiatry, Harvard Medical School
Oscar Bukstein, MD, MPH
Associate Director, Faculty Development, Department of Psychiatry and Behavioral Sciences, Boston Children's Hospital
Professor of Psychiatry, Harvard Medical School
Greg Mattingly, MD
Associate Clinical Professor, Washington University St. Louis
President, American Professional Society of ADHD and Related Disorders (APSARD)
Founding partner, St. Charles Psychiatric Associates
Principal Investigator, Midwest Research Group
Kathleen Nadeau, PhD
Center Director and Founder, The Chesapeake Center, Bethesda, MD
Mary Solanto, PhD
Clinical Psychologist; Professor of Pediatrics and Psychiatry, Zucker School of Medicine at Hofstra-Northwell
Division of Developmental and Behavioral Pediatrics, Department of Pediatrics, Cohen Children’s Medical Center of New York
Mark Stein, PhD, ABPP
Director, PEARL Clinic/ADHD and Related Disorders Program, Seattle Children's Hospital Investigator, Seattle Children's Research Institute
Professor of Psychiatry and Behavioral Science and Professor of Pediatrics, University of Washington
Robyn Thom, MD
Psychiatrist, Lurie Center for Autism, MassGeneral Hospital for Children
Assistant Professor, Harvard Medical School
Course Fees
Fee Disclaimer
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment.
At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
Role | Standard Price | Early Registration Price |
---|---|---|
Physician (MD/DO) | $290.00 | $260.00 |
Nurse (RN/APRN) | $230.00 | $200.00 |
PA | $230.00 | $200.00 |
Psychologist | $230.00 | $200.00 |
Resident/Fellow | $230.00 | $200.00 |
Social Worker | $230.00 | $200.00 |
Allied Health Professional / Other | $230.00 | $200.00 |
This program has been approved for a total of 7.00 Social Work Continuing Education hours for re-licensure, in accordance with 258 CMR. NASW-MA Chapter CE Approval Program Authorization Number D 10289-1. NY Social Workers: Cambridge Health Alliance, Division of Continuing Education in Psychiatry is recognized by the New York State Education Department's State Board for Social Work as an Approved Provider #0038 of continuing education for licensed social workers. This course offers 7.00 contact hours.
Please note: For psychologists, social workers, family therapists and counselors, this course has been approved for a set amount of credits and CHA is not able to issue CE certificates for partial credit. You must be present for all sessions to receive a CE certificate. For any questions regarding CE credit, please email cme@challiance.org.